Revisor Wealth Management LLC

Position in NGEN — Nervgen Pharma Corp.

CIK 1887409 AKRON, OH

Position in NGEN

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$21,836

New position

Shares Held

10,600

first reported quarter

Ownership

0.010%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#51

of 62 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Revisor Wealth Management LLC holds $1,092,156 across 4 Biotechnology names. NGEN ranks #4 (2.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	4,526	$513,067
2	ANRO	Alto Neuroscience, Inc.	17,130	$452,060
3	NUVB	Nuvation Bio Inc.	18,520	$105,193
4	NGEN	Nervgen Pharma Corp. This page	10,600	$21,836

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$21,836	10,600	—	Shares	Sole	2026-07-22
No filing history on record for this holder in this stock.